Usana Health Sciences Inc financial data

Symbol
USNA on NYSE
Location
3838 West Parkway Blvd., Salt Lake City, UT
State of incorporation
Utah
Fiscal year end
December 28
Former names
USANA INC (to 4/27/2000)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 368 % +25.3%
Quick Ratio 54.5 % +7.41%
Return On Equity 11.1 % -22.3%
Return On Assets 8.83 % -17.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.1M shares -1.29%
Common Stock, Shares, Outstanding 19.1M shares -1.28%
Entity Public Float 699M USD -51%
Common Stock, Value, Issued 19K USD 0%
Weighted Average Number of Shares Outstanding, Basic 19.1M shares -1.28%
Weighted Average Number of Shares Outstanding, Diluted 19.2M shares -1.38%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 875M USD -7.67%
Operating Income (Loss) 84.3M USD -12.5%
Nonoperating Income (Expense) 10.1M USD +106%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 94.5M USD -6.79%
Income Tax Expense (Benefit) 39.4M USD +3.79%
Net Income (Loss) Attributable to Parent 55.1M USD -13.1%
Earnings Per Share, Basic 2.88 USD/shares -12.2%
Earnings Per Share, Diluted 2.86 USD/shares -12.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 332M USD +10.7%
Inventory, Net 61.8M USD -0.21%
Other Assets, Current 6.1M USD -14.4%
Assets, Current 419M USD +8.11%
Deferred Income Tax Assets, Net 18.2M USD +14.3%
Property, Plant and Equipment, Net 97.7M USD +2.04%
Operating Lease, Right-of-Use Asset 17.7M USD -11.6%
Intangible Assets, Net (Excluding Goodwill) 28.6M USD -4.53%
Goodwill 16.8M USD -0.13%
Other Assets, Noncurrent 51M USD -9.8%
Assets 631M USD +4.77%
Accounts Payable, Current 6.65M USD -28.3%
Employee-related Liabilities, Current 16.2M USD -6.55%
Liabilities, Current 104M USD -8.73%
Deferred Income Tax Liabilities, Net 4.65M USD -2.98%
Operating Lease, Liability, Noncurrent 5.14M USD -33.1%
Other Liabilities, Noncurrent 10.7M USD -30%
Accumulated Other Comprehensive Income (Loss), Net of Tax -20.5M USD -11%
Retained Earnings (Accumulated Deficit) 464M USD +8.56%
Stockholders' Equity Attributable to Parent 512M USD +9.25%
Liabilities and Equity 631M USD +4.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 17.7M USD +37.8%
Net Cash Provided by (Used in) Financing Activities -11.9M USD -273%
Net Cash Provided by (Used in) Investing Activities -4.07M USD -20.4%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 19.1M shares -1.28%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.14M USD -130%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 335M USD +10.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 24K USD +1100%
Deferred Tax Assets, Valuation Allowance 137M USD +16.2%
Deferred Tax Assets, Gross 177M USD +13%
Operating Lease, Liability 12.4M USD -14.8%
Payments to Acquire Property, Plant, and Equipment 3.2M USD +51.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 53.1M USD -2.44%
Lessee, Operating Lease, Liability, to be Paid 12.9M USD -14.4%
Property, Plant and Equipment, Gross 212M USD +1.2%
Operating Lease, Liability, Current 7.28M USD +5.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.86M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.61M USD +5.48%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +32.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 481K USD -2.24%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.31M USD -29.1%
Deferred Tax Assets, Operating Loss Carryforwards 1.96M USD +13.7%
Unrecognized Tax Benefits 1.07M USD -25.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 121K USD -75.7%
Depreciation, Depletion and Amortization 3.16M USD -4.27%
Deferred Tax Assets, Net of Valuation Allowance 39.4M USD +3.04%
Interest Expense 283K USD +48.2%